Vanguard Group Inc Daxor Corp Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Daxor Corp stock. As of the latest transaction made, Vanguard Group Inc holds 48,828 shares of DXR stock, worth $407,713. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,828
Previous 48,828
-0.0%
Holding current value
$407,713
Previous $455,000
7.25%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DXR
# of Institutions
11Shares Held
87.3KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8KShares$123,7550.0% of portfolio
-
Keyes, Stange & Wooten Wealth Management, LLC Palm Coast, FL14.6KShares$122,0100.07% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ7.2KShares$60,1200.0% of portfolio
-
Ubs Group Ag1.24KShares$10,3200.0% of portfolio
-
Princeton Global Asset Management LLC500Shares$4,1750.0% of portfolio
About DAXOR CORP
- Ticker DXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 4,041,670
- Market Cap $33.7M
- Description
- Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...